Ionis Pharmaceuticals IONS Foreign
Foreign at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CurrentForeignTaxExpenseBenefit.
The official record: Ionis Pharmaceuticals’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's foreign.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's foreign?
- Ionis Pharmaceuticals (IONS) reported foreign of $55.25K in Q4 2025.
- How has Ionis Pharmaceuticals's foreign changed year-over-year?
- Ionis Pharmaceuticals's foreign increased by 30.8% year-over-year, from $42.25K to $55.25K.
- What is the long-term trend for Ionis Pharmaceuticals's foreign?
- Over 2 years (2023 to 2025), Ionis Pharmaceuticals's foreign has grown at a 22.6% compound annual growth rate (CAGR), from $147K to $221K.
- What does foreign mean?
- The current period's income tax expense owed to foreign governments.
- How do you interpret foreign?
- Changes indicate shifts in international profitability or changes in foreign tax regulations.
- How does foreign compare across companies?
- Standard disclosure for multinational entities with international tax footprints.